Rapamycin treatment was shown to significantly increase the LC3-II/LC3-I ratio and Beclin1 expression in the diabetes + SCI group (P < 0.05; Fig. 6A – C); significant decreases were seen for p62 (Fig. 6A,D). Here, BECN1 is linked to diabetes mellitus.